Kathrin Gollmer

499 total citations
11 papers, 235 citations indexed

About

Kathrin Gollmer is a scholar working on Oncology, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Kathrin Gollmer has authored 11 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Otorhinolaryngology. Recurrent topics in Kathrin Gollmer's work include Head and Neck Cancer Studies (4 papers), T-cell and B-cell Immunology (4 papers) and Peptidase Inhibition and Analysis (2 papers). Kathrin Gollmer is often cited by papers focused on Head and Neck Cancer Studies (4 papers), T-cell and B-cell Immunology (4 papers) and Peptidase Inhibition and Analysis (2 papers). Kathrin Gollmer collaborates with scholars based in Switzerland, France and Spain. Kathrin Gollmer's co-authors include Jens V. Stein, Yoshinori Fukui, Mario Mellado, Bart Vanhaesebroeck, Emmanuel Donnadieu, A. MARTIN, Daniela Natale, Sarah E. Henrickson, François Asperti-Boursin and Friederike Pfeiffer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Kathrin Gollmer

11 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathrin Gollmer Switzerland 7 139 91 75 40 15 11 235
Ning Lu Yoshida Japan 7 138 1.0× 99 1.1× 46 0.6× 41 1.0× 14 0.9× 9 242
Ursula Jeffry United States 5 96 0.7× 90 1.0× 48 0.6× 40 1.0× 17 1.1× 10 207
George A. Dominguez United States 5 198 1.4× 73 0.8× 126 1.7× 27 0.7× 16 1.1× 12 279
Hideki Mitsui Japan 11 130 0.9× 132 1.5× 53 0.7× 70 1.8× 20 1.3× 17 340
Marina Roy-Luzarraga United Kingdom 5 68 0.5× 116 1.3× 101 1.3× 48 1.2× 41 2.7× 6 227
Salah Almokadem United States 5 36 0.3× 67 0.7× 73 1.0× 66 1.6× 20 1.3× 9 154
Kangling Xu United States 3 174 1.3× 81 0.9× 130 1.7× 44 1.1× 3 0.2× 7 309
Debra A. Tanguay United States 8 120 0.9× 83 0.9× 71 0.9× 6 0.1× 12 0.8× 10 200
Amal J. Ali United States 6 108 0.8× 69 0.8× 31 0.4× 24 0.6× 15 1.0× 11 188
Béatrice Le Maux Chansac France 6 316 2.3× 60 0.7× 182 2.4× 34 0.8× 26 1.7× 6 401

Countries citing papers authored by Kathrin Gollmer

Since Specialization
Citations

This map shows the geographic impact of Kathrin Gollmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Gollmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Gollmer more than expected).

Fields of papers citing papers by Kathrin Gollmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Gollmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Gollmer. The network helps show where Kathrin Gollmer may publish in the future.

Co-authorship network of co-authors of Kathrin Gollmer

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Gollmer. A scholar is included among the top collaborators of Kathrin Gollmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Gollmer. Kathrin Gollmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Feldman, Darren R., Ben Tran, Louise Emmett, et al.. (2023). First-in-human clinical trial design of a first-in-class theranostic approach with a peptide-based radioligand targeting CA IX-expressing tumors.. Journal of Clinical Oncology. 41(16_suppl). TPS3160–TPS3160. 2 indexed citations
3.
4.
Tourneau, Christophe Le, Yungan Tao, Carlos Gomez‐Roca, et al.. (2020). Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research. 26(24). 6429–6436. 22 indexed citations
5.
6.
7.
Jankú, Filip, Gopa Iyer, Anna Spreafico, et al.. (2018). A phase I study of LXH254 in patients (pts) with advanced solid tumors harboring MAPK pathway alterations.. Journal of Clinical Oncology. 36(15_suppl). 2586–2586. 11 indexed citations
8.
Gollmer, Kathrin, Philipp Germann, Xenia Ficht, et al.. (2017). Antigen Availability and DOCK2-Driven Motility Govern CD4+ T Cell Interactions with Dendritic Cells In Vivo. The Journal of Immunology. 199(2). 520–530. 10 indexed citations
9.
Lamana, Amalia, Pilar Martı́n, Hortensia de la Fuente, et al.. (2011). CD69 Modulates Sphingosine-1-Phosphate-Induced Migration of Skin Dendritic Cells. Journal of Investigative Dermatology. 131(7). 1503–1512. 45 indexed citations
10.
Boscacci, Rémy, Friederike Pfeiffer, Kathrin Gollmer, et al.. (2010). Comprehensive analysis of lymph node stroma-expressed Ig superfamily members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and VCAM-1 in lymphocyte homing. Blood. 116(6). 915–925. 77 indexed citations
11.
Gollmer, Kathrin, François Asperti-Boursin, Yoshihiko Tanaka, et al.. (2009). CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway. Blood. 114(3). 580–588. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ning Lu Yoshida Breakdown of academic impact, for papers by Ursula Jeffry Breakdown of academic impact, for papers by George A. Dominguez Breakdown of academic impact, for papers by Hideki Mitsui Breakdown of academic impact, for papers by Marina Roy-Luzarraga Breakdown of academic impact, for papers by Salah Almokadem Breakdown of academic impact, for papers by Kangling Xu Breakdown of academic impact, for papers by Debra A. Tanguay Breakdown of academic impact, for papers by Amal J. Ali Breakdown of academic impact, for papers by Béatrice Le Maux Chansac
Rankless by CCL
2026